传统医学
掺假者
质量标准
药典
医学
色谱法
化学
病理
替代医学
作者
Tian-Ying Jia,Xiaonan Zhang,Tai Chao Su,Xiaoyan Yang,Haili Wang,Jie-Ping Xin,Mengnan Liu,Jingkun Wang,Xiang-Ri Li
出处
期刊:PubMed
日期:2020-05-01
卷期号:45 (10): 2425-2430
被引量:1
标识
DOI:10.19540/j.cnki.cjcmm.20200110.201
摘要
Thin layer chromatography, high performance liquid chromatography and multivariate statistical analysis were integrated in current study to provide a basis for the quality evaluation and the standard improvement of Paridis Rhizoma(Chinese name: Chong-lou). The results demonstrated that the primary saponins in the two authorized sources of Paridis Rhizoma were polyphyllinsⅠ, Ⅱ and Ⅶ, while the rhizome of Trillium tschonoskii an adulterant of Paridis Rhizoma was rich of polyphyllin Ⅵ. Therefore, the apparent content of polyphyllin Ⅵ plays a determinant role towards the source authentication of raw materials and decoction slices of Paridis Rhizoma, whose adulterants frequently occur in the market. Moreover, the contents of polyphyllin Ⅵ in the two authorized sources could meet the requirements of Chinese Pharmacopoeia. Therefore, we suggested that polyphyllin Ⅵ should not be omitted from the quality standard of Paridis Rhizoma in the Chinese Pharmacopoeia, and on the other side, polyphyllinsⅠ, Ⅱ and Ⅶ should be the eligible quality indicators. The study aims to sound information and evidences for the quality evaluation of Paridis Rhizoma, and also to provide a theoretical basis for the standard revision of Paridis Rhizoma in the future Chinese Pharmacopoeia.
科研通智能强力驱动
Strongly Powered by AbleSci AI